Natural Investments’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.99M Buy
15,454
+865
+6% +$101K 0.44% 44
2026
Q1
$1.75M Sell
14,589
-99
-0.7% -$11.4K 0.43% 47
2025
Q4
$1.55M Buy
14,688
+985
+7% +$92.5K 0.38% 60
2025
Q3
$1.15M Sell
13,703
-56
-0.4% -$4.61K 0.29% 77
2025
Q2
$1.09M Buy
13,759
+1,188
+9% +$94.4K 0.28% 80
2025
Q1
$1.13M Sell
12,571
-1,413
-10% -$132K 0.32% 81
2024
Q4
$1.39M Buy
+13,984
New +$1.44M 0.39% 68

Other funds holding MRK

Natural Investments's MRK Position: Q2 2026 in Review

Natural Investments increased its Merck (MRK) stake by 5.9% in Q2 2026, buying an estimated $101K and bringing the position to 15,454 shares worth $1.99M. The position accounts for 0.44% of the portfolio, ranked #44.

Natural Investments first reported a position in MRK in Q4 2024 and has held it in 7 quarters since. 1,867 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • Natural Investments held 15,454 shares of Merck worth $1.99M as of Q2 2026.
  • Natural Investments bought 865 Merck shares in Q2 2026, an estimated $101K.
  • Merck made up 0.44% of Natural Investments's portfolio in Q2 2026, its #44 holding.
  • Natural Investments first reported a position in Merck in Q4 2024 and has held it in 7 quarters since.
  • 1,867 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on Natural Investments's 13F filing for Q2 2026, filed 31 Jul 2026.